Actions

Get instant AI-powered insights about company performance, financials, and strategy. Ask questions about trends, competition, and developments while receiving responses backed by official documents and market data, with clear attribution to source documents.


Pharmaceuticals & Biotechnology
Pharmaceuticals
483 Cr
Low Risk
21.4
37.7
0.1
1.2
925.00
581.30
Sales CAGR
Profit CAGR
ROE
ROCE
Albert David Ltd (ALBERTDAVD) is currently trading at 848.15 per share. Stock prices fluctuate during market hours on NSE and BSE based on demand, company updates, and overall market conditions. Refer to the live price chart above for the most recent price movement.
Albert David Limited (ADL) specializes in manufacturing and trading pharmaceutical formulations, infusion solutions, herbal dosage forms, and bulk drugs, both domestically and internationally. The company is a significant player in the IV fluid manufacturing sector, with production capabilities in both glass and polyethylene containers. ADL has engaged in several technical collaborations, notably with Morishita Pharmaceuticals for amino acid infusions and Pharma Plan, Germany for syringe and needle manufacturing. Over the years, ADL has consistently launched new pharmaceutical products across various categories, reflecting its focus on innovation and market adaptation. ADL is part of the Kothari Group, a prominent industrial house in Kolkata, highlighting a strong backing in capital and strategic direction.
Over the past 52 weeks, Albert David Ltd has traded between a low of ₹581.30 and a high of ₹925.00. The 52-week high and low indicate the stock’s price range over the last year and help investors understand its volatility and recent trading levels.
Albert David Ltd has a market capitalization of approximately 482.78. Market capitalization represents the total value of a company’s outstanding shares and helps investors understand its size, stability, and relative risk compared to other listed companies.
Albert David Ltd’s investment profile depends on its business fundamentals, valuation, and long-term outlook. The stock currently trades at a PE ratio of 21.39 and operates in the its sector sector. Investors typically assess financial performance, growth prospects, and individual risk tolerance before making investment decisions.
Based on its market capitalization of 482.78 Cr, Albert David Ltd is classified as a Small Cap stock. Large-cap stocks are generally more stable, while mid-cap and small-cap stocks tend to offer higher growth potential along with higher price volatility.
Albert David Ltd operates in the its sector sector. Sector classification matters because companies in the same sector are often affected by similar economic conditions, regulatory changes, and competitive dynamics, which can influence overall stock performance.
The Price-to-Earnings (PE) ratio of Albert David Ltd is 21.39. The PE ratio compares a company’s share price to its earnings and is commonly used to assess valuation. Comparing the PE ratio with sector peers and historical levels provides better context.
Bearish
2
Neutral
6
Bullish
6
Bearish
16
Neutral
6
Bullish
24
Bearish
14
Neutral
0
Bullish
18
Bearish
2
Neutral
6
Bullish
6
Bearish
2
Neutral
6
Bullish
6
Bearish
14
Neutral
0
Bullish
18
Bearish
14
Neutral
0
Bullish
18
Bearish
14
Neutral
0
Bullish
18
